NCT05212285View on ClinicalTrials.gov

Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

469

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
SarcopeniaNon Small Cell Lung CancerMalnutrition
Interventions
DEVICE

Inbody 570

Bioelectrical Impedance Analysis with Inbody 570 (Inbody Co., Seoul, Korea) during each follow-up

DEVICE

JAMAR Dynamometer

Handgrip strength measurement using a JAMAR Dynamometer (JAMAR Co., Ltd., USA) during each follow-up

RADIATION

CT scan

Chest and abdominal CT scan during each follow-up

Trial Locations (1)

200040

Huadong hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT05212285 - Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter